Skip to main content
Caplight Logo









Sequential

Sequential

Private
LondonHealthcare & Life Scienceshttps://www.sequential.bio/

Last Round

Seed

Mar 17, 2026

Total Funding Raised

$7.95M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Sequential is a biotechnology company that provides an in-vivo microbiome testing platform for the personal care and pharmaceutical industries.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Fashion & Beauty, Healthcare Analytics

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Keywords

skin microbiomemicrobiome analysisclinical trialskincare efficacyclaim substantiationbeauty techbiotechCROclinical research organizationmulti-omic dataingredient discoverypredictive modelingdermocosmeticsmicrobiome testingAI-driven discovery

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Sequential Comparables

Compare Sequential with similar companies based on industry and business-model similarity.

Sequential comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
HelloBiome
85%
MyMicrobiome
78%
DeepVerge plc
77%

Sequential Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedMar 17, 2026
GrantFeb 13, 2025
SeedMay 25, 2023
GrantJun 29, 2022
SeedOct 11, 2021
Pre Seed
Mar 17, 2021

Key People

Founding team and executive leadership

Oliver Worsley

Co-Founder CEO

Founding Team

Sequential Investors

Notable investors and investment history

Sequential investors
InvestorRounds
Innovate UKGrant
Startup SGGrant
Dermazone HoldingsSeed
Metaplanet HoldingsSeed
Innovate UKGrant, Seed
Corundum Systems BiologySeed
IndieBioPre Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 17, 2026

    Raised $3.5M in early funding.

  • Mar 4, 2026

    Collected over 50,000 human skin microbiome samples.

Sequential Filings

Explore SEC and related filing metadata, where available.

Sequential filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Sequential's valuation, stock price, and market status.

Is Sequential a public or private company?

Sequential is a private company.

What is the current stock price of Sequential?

Sequential is a private company with no public stock price. No recent secondary market data is available.

How much is Sequential worth (valuation)?

Valuation information for Sequential is not publicly available.

Can I buy Sequential stock?

Sequential shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Sequential's last funding round?

Sequential's most recent funding round was Early Funding on March 17, 2026.

Who are the main investors in Sequential?

Key investors in Sequential include Corundum Systems Biology, Sparkfood, SOSV.

Will Sequential IPO soon?

No public IPO plans have been announced for Sequential.

How can I track Sequential secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Sequential's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersLondon
Employee Range14
Year Founded2019
Last FundingMar 17, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?